Embattled Canadian cannabis stocks have been climbing on the hope that the U.S. may ease restrictions on the substance.
The Associated Press reported that the U.S. health department has recommended marijuana be moved from a schedule one to a schedule three controlled substance.
U.S. Senate leaders hailed the recommendation Wednesday as a first step toward easing federal restrictions on cannabis.
OBJ360 (Sponsored)
Public-private collaboration is Canada’s innovation engine — but it needs fuel
Fidus Systems Inc.’s selection last year as AMD Adaptive Compute Partner of the Year is a reflection of the world-class talent the company has assembled in Ottawa. As the first
Legal tips for making workplace changes during a period of economic uncertainty
With the ongoing threat of severe trade disruptions and economic uncertainty in the air, business owners who have been economically impacted by the tariffs might be contemplating changes to their
Shares in Canopy Growth Corp. were up almost 36 per cent around noon Thursday, after climbing nine per cent Wednesday.
Tilray Brands Inc. shares were up almost 12 per cent, after its stock rose more than 10 per cent Wednesday.
Shares of Aurora Cannabis Inc. were up almost eight per cent around noon on Thursday.
